These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 2784112

  • 1. Increase of glucose and lactate output and decrease of flow by human anaphylatoxin C3a but not C5a in perfused rat liver.
    Püschel GP, Oppermann M, Muschol W, Götze O, Jungermann K.
    FEBS Lett; 1989 Jan 16; 243(1):83-7. PubMed ID: 2784112
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of human anaphylatoxin C3a on glucose output and flow in rat liver during orthograde and retrograde perfusion: the periportal scavenger cell hypothesis.
    Püschel GP, Oppermann M, Neuschäfer-Rube F, Götze O, Jungermann K.
    Biochem Biophys Res Commun; 1991 May 15; 176(3):1218-26. PubMed ID: 2039507
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of anaphylatoxin C3a- and C5a- but not nerve stimulation- or Noradrenaline-dependent increase in glucose output and reduction of flow in Kupffer cell-depleted perfused rat livers.
    Püschel GP, Nolte A, Schieferdecker HL, Rothermel E, Götze O, Jungermann K.
    Hepatology; 1996 Sep 15; 24(3):685-90. PubMed ID: 8781343
    [Abstract] [Full Text] [Related]

  • 4. Modulation of the immune response by anaphylatoxins.
    Morgan EL.
    Complement; 1986 Sep 15; 3(3):128-36. PubMed ID: 3542364
    [Abstract] [Full Text] [Related]

  • 5. Anaphylatoxin-induced release of histamine from in vitro perfused guinea pig kidney.
    Abdullah NA, Assem ES, Damerau B.
    Agents Actions; 1988 Apr 15; 23(3-4):181-4. PubMed ID: 2455983
    [Abstract] [Full Text] [Related]

  • 6. Effects of human anaphylatoxins on guinea pig atria.
    Huey R, Bloor CM, Hugli TE.
    Immunopharmacology; 1984 Dec 15; 8(3-4):147-54. PubMed ID: 6335143
    [Abstract] [Full Text] [Related]

  • 7. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
    Marceau F, Hugli TE.
    J Pharmacol Exp Ther; 1984 Sep 15; 230(3):749-54. PubMed ID: 6332191
    [Abstract] [Full Text] [Related]

  • 8. Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).
    Sorgenfrei J, Damerau B, Vogt W.
    Agents Actions; 1982 Apr 15; 12(1-2):118-21. PubMed ID: 6177210
    [Abstract] [Full Text] [Related]

  • 9. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP, Hugli TE, Bloor CM.
    Am J Pathol; 1980 Aug 15; 100(2):327-48. PubMed ID: 6967702
    [Abstract] [Full Text] [Related]

  • 10. Chemotactic effects of the complement-derived peptides C3a, C3ai and C5a (classical anaphylatoxin) on rabbit and guinea-pig polymorphonuclear leukocytes.
    Damerau B, Grünefeld E, Vogt W.
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Nov 15; 305(2):181-4. PubMed ID: 732894
    [Abstract] [Full Text] [Related]

  • 11. Anaphylatoxin-mediated regulation of human and murine immune responses.
    Morgan EL, Weigle WO, Hugli TE.
    Fed Proc; 1984 Jul 15; 43(10):2543-7. PubMed ID: 6610569
    [Abstract] [Full Text] [Related]

  • 12. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.
    Meuer S, Hugli TE, Andreatta RH, Hadding U, Bitter-Suermann D.
    Inflammation; 1981 Dec 15; 5(4):263-73. PubMed ID: 6976935
    [Abstract] [Full Text] [Related]

  • 13. Cardiac anaphylaxis. Complement activation as an amplification system.
    del Balzo U, Polley MJ, Levi R.
    Circ Res; 1989 Sep 15; 65(3):847-57. PubMed ID: 2475275
    [Abstract] [Full Text] [Related]

  • 14. Modulation of the immune response by anaphylatoxin in the microenvironment of the interacting cells.
    Weigle WO, Morgan EL, Goodman MG, Chenoweth DE, Hugli TE.
    Fed Proc; 1982 Dec 15; 41(14):3099-103. PubMed ID: 6216123
    [Abstract] [Full Text] [Related]

  • 15. Anaphylatoxin-induced neutrophil chemotaxis and aggregation. Limited aggregation and specific desensitization induced by human C3a and synthetic C3a octapeptides.
    Nagata S, Glovsky MM, Kunkel SL.
    Int Arch Allergy Appl Immunol; 1987 Dec 15; 82(1):4-9. PubMed ID: 3492446
    [Abstract] [Full Text] [Related]

  • 16. Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease.
    Belmont HM, Hopkins P, Edelson HS, Kaplan HB, Ludewig R, Weissmann G, Abramson S.
    Arthritis Rheum; 1986 Sep 15; 29(9):1085-9. PubMed ID: 3489467
    [Abstract] [Full Text] [Related]

  • 17. Immunopharmacology of anaphylatoxin-induced bronchoconstrictor responses.
    Stimler-Gerard NP.
    Complement; 1986 Sep 15; 3(3):137-51. PubMed ID: 3026723
    [Abstract] [Full Text] [Related]

  • 18. Isolation of three separate anaphylatoxins from complement-activated human serum.
    Hugli TE, Gerard C, Kawahara M, Scheetz ME, Barton R, Briggs S, Koppel G, Russell S.
    Mol Cell Biochem; 1981 Dec 04; 41():59-66. PubMed ID: 6977086
    [Abstract] [Full Text] [Related]

  • 19. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ, Das C, Bennett D, Terman DS.
    J Immunol; 1984 Aug 04; 133(2):1057-63. PubMed ID: 6610702
    [Abstract] [Full Text] [Related]

  • 20. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
    Gerard C, Hugli TE.
    Proc Natl Acad Sci U S A; 1981 Mar 04; 78(3):1833-7. PubMed ID: 6940191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.